High Hope Pharmaceutical Company and Nanjing Economic and Technological Development Zone carry out docking and exchange

On June 18th, High Hope Pharmaceutical Company held a special docking activity with Nanjing Economic and Technological Development Zone. Wang Jiajia, Deputy General Manager of Xingang Biopharmaceutical Company in Nanjing Economic Development Zone, visited High Hope Pharmaceutical Company with officials from the Investment and Operation Department, the Science and Technology Bureau of the Economic Development Zone, and four pharmaceutical enterprise leaders for exchange and discussion. Members of the leadership team of the pharmaceutical company and relevant department heads attended the event.

Wang Jiajia introduced the basic situation of Nanjing Economic Development Zone and the pharmaceutical enterprises in the zone, and said that Nanjing Economic Development Zone is actively building an innovative industrial cluster represented by biomedicine. High Hope Pharmaceutical Co., Ltd. has rich experience in the pharmaceutical industry for many years, a marketing network covering major global pharmaceutical markets, and a professional international operation team. He hoped to take this event as an opportunity to promote the docking between enterprises in the zone and High Hope Pharmaceutical Co., Ltd., and deepen links in "going to sea" and exploring the market layout of the "the Belt and Road", so as to promote the improvement of quality and efficiency, transformation and upgrading of enterprises. Officials from four companies, Nanjing Ruibeixi Biotechnology, Yilanbei Biotechnology, Renmai Biotechnology, and Yiwei Jianhua Biotechnology, introduced their development history, core products, and market strategies, with a focus on their respective technological advantages in the fields of magnetic nanomaterials, in vitro diagnostic equipment, characteristic detection reagents, and precision diagnosis and treatment of extracellular vesicles. They also exchanged ideas on the direction of docking and cooperation opportunities with pharmaceutical companies.

The pharmaceutical company provided a detailed introduction to its historical evolution, strategic planning, and main business segments. It stated that as a professional enterprise engaged in pharmaceutical and medical business under the SOHO   Holdings Group, it is striving to promote the sharing of resources and channel elements, and to build a convenient platform and provide service guarantees for cooperative enterprises to expand overseas markets. This special session is a crucial step for both parties to integrate resources and seek collaborative development. The innovative vitality and latest cutting-edge technologies in biomedicine gathered in Nanjing Economic Development Zone are worth learning from for pharmaceutical companies. Pharmaceutical companies hope to become a solid bridge for enterprises in the region to "go to sea". They are willing to provide customized overseas marketing solutions for enterprises in the region, focusing on exploring the "the Belt and Road" markets in Central Asia, Africa, South America, etc., accelerating technology transformation, expanding market share, and improving the international competitiveness of the bio pharmaceutical industry in the Economic Development Zone.

Both sides had practical and in-depth exchanges with a warm atmosphere, and agreed that this docking activity has laid a good foundation for deepening cooperation. In the future, a normalized docking mechanism will be established, on-site investigations will be conducted in enterprises, a specific list of cooperation projects will be sorted out, and precise matching of advantageous resources will be promoted. Efforts will be made to make substantial progress in product overseas and technology transformation as soon as possible, and to inject new momentum into the high-quality development and international layout of the biopharmaceutical industry together.